AsCNP Science Award

AsCNP Science Award 2025

The AsCNP has been presenting its science award since 2019. This award recognizes two winners—one from clinical research and one from basic research—honoring their outstanding achievements in the field of neuropsychopharmacology. Each winner will receive a monetary prize of $2,000 (USD), which will be presented at the CINP-AsCNP 2025 meeting in Melbourne. (Award Lecture: 16 June 2025, AM)

Guidelines

Both the nominator and the nominee must be members of AsCNP.
The nominator’s letter of recommendation should include a one- to three-page statement summarizing the nominee’s current work, activities, and achievements.
The nominee’s curriculum vitae should include a list of publications.
Applications will be accepted from 17 January 2025 to 21 February 2025. The results will be announced on 1 April 2025.
Applications should be sent to the AsCNP Central Office via email at secretariatascnp.org.

Please fax or mail this application to：

Asian College of Neuropsychopharmacology (AsCNP)
c/o A & E Planning Co., Ltd.

E-mail : secretariatascnp.org
Fax : +81-3-3230-2479

Awardee

2023 Awardee
Clinical Science Award
Cheng-Ta Li (Taiwan)	Division Chief, Division of Community & Rehabilitation Psychiatry, Department of Psychiatry, Taipei Veterans General Hospital Laboratory Head, Functional Neuroimaging and Brain Stimulation Lab Director, Precision Depression Intervention Center Professor, Department of Psychiatry, National Yang-Ming Chiao-Tung University Professor, Institute of Brain Science, National Yang-Ming Chiao-Tung University Professor, Institute of Cognitive Neuroscience, National Central University
Basic Science Award
Gavin Stewart Dawe (Singapore)	The Head of the Department of Pharmacology at the Yong Loo Lin School of Medicine, The Director of the Neuroscience and Metabolic Phenotyping Core at the National University of Singapore

In the science award of AsCNP 2023, there are four applicants for the clinical field and one for the basic research field. After the scoringby the Award Committee, we are pleased to announce that Prof. Cheng-Ta Li has won the Clinical Science Award, and Prof. Gavin Stewart has won the Basic Science Award.

Prof. Cheng-Ta Li is a senior psychiatrist and an outstanding professor at National Yang Ming Chiao Tung University, Taipei, Taiwan. Prof. Li has long been devoted to the field of treatment-resistant depression (TRD) and has published more than 200 SCI papers. He is ranked in the top 1% in the field of TRD with multidisciplinary expertise, according to the results of Expertscape (2011-2021).

Prof. Dawe is the Head of the Department of Pharmacology at the Yong Loo Lin School of Medicine, as well as the Director of the Neuroscience and Metabolic Phenotyping Core at the National University of Singapore. Dr. Dawe has focused on the study of antipsychotics, antidepressants, anxiolytics, and modulators of cognitive function and neuroplasticity. His scientific work in animal models of schizophrenia, depression, anxiety, and dementia is outstanding and has consistently contributed to significant advancements in the field.

Our President, Tianmei Si, will invite them to give a special lecture during the AsCNP Congress Xi'an 2023.

Shih-Ku Lin,
Chair, Science Award Selection Committee

2021 Awardee
Tadafumi Kato (Japan)	The Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan
Zhong Chen (China)	The President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

For the second Lundbeck Science Award, there are seven applicants for clinical and only one for basic research field. After the scoring from the Award Committee, we are pleased to announce that Prof Tadafumi Kato wins the Clinical Science and Prof Zhong Chen wins the basic Science Award. Prof Tadafumi Kato is the Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine. Tokyo, Japan. Prof Kato has published more than 300 Peer-reviewed original research articles and his major research interest is in the field of neuropsychopharmacology of bipolar disorder. Prof Chen is the President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. He has published more than 250 Peer-reviewed original research articles and his major research interest is in the field of neural circuit basis & molecular mechanisms of epileptogenesis and the development of antiepileptic drugs and the roles of histamine and histamine receptors in neurological disorder and the involvement of autophagy. Our President Tan Chay Hoon will invite them to give a special lecture during AsCNP Congress Singapore 2021.

Shih-Ku Lin,
Chair, Lundbeck Science Award Committee

2019 Awardee
Toshi A. Furukawa (Japan)	Professor and Chair of the Department of Health Promotion and Human Behavior, Professor of the Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan. He has published more than 400 Peer-reviewed original research articles and his major research interest is in the field of mood disorders.
Brian Dean (Australia)	Head, The Molecular Psychiatry Laboratory, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia. Deputy Director, The Victorian Brain Bank Network, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia. Principal Research Fellow, Centre for Mental Health, Swinburne University of Technology, Hawthorn, Australia. Professorial Fellow, University of Melbourne, Parkville, Australia. He has published more than 250 Peer-reviewed original research articles and his major research interest is in the field of molecular abnormalities underpinning the pathophysiology of psychiatric disorders and new drug target of for treatment.